H7692

Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).

Introduced·2/11/26
Introduced Text

Rhode Island H7692 aims to control Medicaid prescription drug costs by enhancing transparency and accountability for managed care organizations and.

Rhode Island H7692 seeks to protect Rhode Islanders and the state Medicaid program from high prescription drug costs. It imposes transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs). The bill mandates that PBMs cease activities like spread pricing, where they charge more than the reimbursement amount to pharmacies, and discriminatory treatment of non-affiliated pharmacies. It also requires PBMs to stop utilization management processes that delay or prevent medically necessary care.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Finance Committee
Next
Committee decision

Sponsors

DDDDDDDDDD
10
0
Democratic CaucusRepublican Caucus

Calendar

May 5

12:00 AM

House Finance Hearing

History

May 5

House

Committee recommended measure be held for further study

May 1

House

Scheduled for hearing and/or consideration (05/05/2026)

Feb 11

House

Introduced, referred to House Finance